Sign Up for our Newsletter
Noninvasive prenatal testing for greater accuracy
More women deserve the right to NIPT
Expert Insights & Resources
Expand your knowledge with articles, training resources, news & webcasts for professionals and advocates alike.
Universal access to NIPT: Cost-effective and precise cell-free DNA testing
Making NIPT accessible to all women
Implementation and Validation of a High-Precision, Non-NGS NIPT Platform
Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategies
What You Can Screen For
Trisomy 21 (Down syndrome)
Trisomy 18 (Edwards syndrome)
Trisomy 13 (Patau syndrome)
Vanadis® NIPT platform: Built for All
Unlike complex and expensive sequencing-based platforms, Vanadis NIPT enables cost-efficient and high-performance screening for fetal aneuploidies. Making cell-free DNA testing accessible to more laboratories and more women, Vanadis is built for all.
Vanadis® NIPT system
Laboratory data management software – LifeCycle™ software
Take the next step
Speak with a sales person
Talk to one of our product experts about the right solutions for you.
View more resources
Explore our articles and resources section for the latest information.
- Practice Bulletin Number 226: Screening for fetal chromosomal abnormalities. Obstet Gynecol. 2020; 136(4)
- Benn P, Borrell A, Chiu R, et al. Position statement from the Chromosome Abnormality Screening Committee. Prenat Diagn. 2015;35(8):725-734.
Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.